General Information:

Id: 1,572 (click here to show other Interactions for entry)
Diseases: Atherosclerosis
Diabetes mellitus, type II - [OMIM]
Insulin resistance
Homo sapiens
Reference: Mandosi E et al.(2010) Atorvastatin downregulates monocyte CD36 expression, nuclear NFkappaB and TNFalpha levels in type 2 diabetes J. Atheroscler. Thromb. 17: 539-545 [PMID: 20134099]

Interaction Information:

Comment Atorvastatin therapy, beside lowering serum cholesterol levels, could exert anti-atherogenic and anti-inflammatory effects in type 2 diabetic patients.
Formal Description
Interaction-ID: 13618

drug/chemical compound


decreases_activity of

in type 2 diabetics
Drugbank entries Show/Hide entries for Atorvastatin